Skystar Bio-pharmaceutical Co. (fka SKBI)

[236T568]

actually, wrong yet again

cash that was booked in 2014 from collecting Accounts Receivable in 2014 and that was INCLUDED in the 2014 financial statements NOW HAS TO BE BE REDUCED BY $16 MILLION

which means that the $16 million that they showed in cash as of the June 30, 2014 Balance Sheet, never existed

to not understand this is just plain silly

Quote:
As a result, the Registrant expects that its accounts receivable will increase by approximately $24 million and unrestricted cash will decrease by approximately $16 million

Hahaha... you call that "missing"?

Cash is going down because they didn't collect it, YET.
Get it now?

Unreal.